Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Dutasteride may reduce insulin sensitivity and increase body fat.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Genes and hormones cause hair loss, with four genes contributing equally.

Finasteride doesn't affect hormone levels in normal men.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Testosterone changes how certain channels work in male rat reproductive tracts, affecting fertility-related fluid balance.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.